Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients
This study is currently recruiting participants.
Verified by Korea Otsuka Pharmaceutical Co.,Ltd., October 2007
Sponsors and Collaborators: Korea Otsuka Pharmaceutical Co.,Ltd.
Otsuka Pharmaceutical Co., Ltd.
Information provided by: Korea Otsuka Pharmaceutical Co.,Ltd.
ClinicalTrials.gov Identifier: NCT00549952
  Purpose

to survey oral mucositis after chemotherapy and Concurrent chemoradiotherapy in Korean cancer patients


Condition Intervention
Oral Mucositis
Other: no intervention study

MedlinePlus related topics: Cancer
U.S. FDA Resources
Study Type: Observational
Study Design: Prospective
Official Title: Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

Further study details as provided by Korea Otsuka Pharmaceutical Co.,Ltd.:

Primary Outcome Measures:
  • incidence and severity of oral mucositis

Study Start Date: October 2007
Estimated Study Completion Date: March 2008
  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients diagnosed with one cancer among head and neck cancer, esophageal cancer, breast cancer, colorectal cancer, gastric cancer, and non-small cell lung cancer, who are being treated or going to be treated as one between A and B A. Chemotherapy only B. Concurrent chemoradiotherapy

Exclusion Criteria:

  • Patients who are pregnant or breast feeding, absent from effective(medically proven) contraceptive method for females of childbearing potential
  • Patients with performance status of ECOG score is more than 3
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00549952

Contacts
Contact: Yonghui Jeong 82-2-3465-3956 jeongyh@otsuka.co.kr
Contact: Boyoun Seo 82-2-3465-5485 byseo@otsuka.cokr

Locations
Korea, Republic of
Seoul National University hospital Recruiting
Seoul, Korea, Republic of, 110-744
Principal Investigator: Do-Youn Oh            
Sponsors and Collaborators
Korea Otsuka Pharmaceutical Co.,Ltd.
Otsuka Pharmaceutical Co., Ltd.
Investigators
Principal Investigator: Do-Youn Oh, PhD Seoul National University Hospital
  More Information

Study ID Numbers: 256-KOB-0701
Study First Received: October 25, 2007
Last Updated: October 25, 2007
ClinicalTrials.gov Identifier: NCT00549952  
Health Authority: South Korea: Institutional Review Board

Study placed in the following topic categories:
Mouth Diseases
Digestive System Diseases
Stomatitis
Mucositis
Gastrointestinal Diseases
Stomatognathic Diseases
Gastroenteritis

ClinicalTrials.gov processed this record on January 15, 2009